Insights on the Neurology Devices Global Market to 2025 – Detailed and Extensive Market Overview with Key Analyst Insights – GlobeNewswire

August 10, 2020 10:28 ET | Source: Research and Markets

Dublin, Aug. 10, 2020 (GLOBE NEWSWIRE) -- The "Neurology Devices Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising spinal cord injuries are further encouraging the adoption of spinal cord stimulation (SCS) devices. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. SCS is normally used for the treatment of chronic pain in the limbs and trunk; however, it can also support enhance control and improve stiff or rigid muscles after a spinal cord injury. Therefore, the demand for spinal cord stimulation may be significantly used to treat spinal cord injuries.

Geographically, the market is classified into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2018, North America is anticipated to hold significant share in the market owing to the increasing number of neurosurgeries coupled with the significant prevalence of neurological disorders in the region. Asia-Pacific is estimated to witness considerable growth during the forecast period owing to the rising ageing population and associated neurological disorders in the region. In addition, increasing awareness regarding neurological disorders will further accelerate the number of neurosurgeries, which thereby will drive the adoption of neurology devices in the region.

Some crucial players operating in the market include Medtronic plc, Abbott Laboratories, Boston Scientific Corp., B. Braun Melsungen AG, and Stryker Corp. Mergers and acquisitions and product launches are some crucial strategies adopted by the market players to expand market share and gain a competitive advantage. For instance, in January 2020, Medtronic plc declared the acquisition of Stimgenics, LLC, a provider of novel spinal cord stimulation (SCS) waveform which is known as Differential Target Multiplexed (DTM) SCS. The therapy, which is delivered through the Medtronic Intellis platform, is a new and unique programming option for the treatment of patients suffering from chronic pain. DTM SCS therapy is a new proprietary SCS waveform that will be available on Medtronic Intellis platform.

The Report covers:

Key Topics Covered:

1. Report Summary 1.1. Research Methods and Tools 1.2. Market Breakdowns 1.2.1. By Segments 1.2.2. By Geography 1.2.3. By Stakeholders

2. Market Overview and Insights 2.1. Scope of the Report 2.2. Analyst Insight & Current Market Trends 2.2.1. Key Findings 2.2.2. Recommendations 2.2.3. Conclusion 2.3. Rules & Regulations

3. Competitive Landscape 3.1. Company Share Analysis 3.2. Key Strategy Analysis 3.3. Key Company Analysis 3.3.1. Medtronic plc 3.3.1.1. Overview 3.3.1.2. Financial Analysis 3.3.1.3. SWOT Analysis 3.3.1.4. Recent Developments 3.3.2. Abbott Laboratories 3.3.2.1. Overview 3.3.2.2. Financial Analysis 3.3.2.3. SWOT Analysis 3.3.2.4. Recent Developments 3.3.3. Boston Scientific Corp. 3.3.3.1. Overview 3.3.3.2. Financial Analysis 3.3.3.3. SWOT Analysis 3.3.3.4. Recent Developments 3.3.4. B. Braun Melsungen AG 3.3.4.1. Overview 3.3.4.2. Financial Analysis 3.3.4.3. SWOT Analysis 3.3.4.4. Recent Developments 3.3.5. Stryker Corp. 3.3.5.1. Overview 3.3.5.2. Financial Analysis 3.3.5.3. SWOT Analysis 3.3.5.4. Recent Developments

4. Market Determinants 4.1 Motivators 4.2 Restraints 4.3 Opportunities

5. Market Segmentation 5.1. Global Neurology Devices Market by Product 5.1.1. Cerebrospinal Fluid Management Devices 5.1.2. Neurostimulation Devices 5.1.2.1. Deep Brain Stimulation 5.1.2.2. Spinal Cord Stimulation 5.1.2.3. Sacral Nerve Stimulation 5.1.2.4. Others 5.1.3. Interventional Neurology Devices 5.1.3.1. Aneurysm Coiling and Embolization 5.1.3.2. Neurothrombectomy Devices 5.1.3.3. Neurovascular Catheters 5.1.3.4. Cerebral Balloon Angioplasty &Stents 5.1.4. Neurosurgery Devices 5.1.4.1. Neuroendoscopes 5.1.4.2. Aneurysm Clips 5.1.4.3. Stereotactic Systems 5.1.4.4. Others 5.1.5. Others 5.2. Global Neurology Devices Market by End-User 5.2.1. Hospitals 5.2.2. Neurology Clinics 5.2.3. Ambulatory Surgical Centers (ASCs)

6. Regional Analysis 6.1. North America 6.1.1. United States 6.1.2. Canada 6.2. Europe 6.2.1. UK 6.2.2. Germany 6.2.3. Italy 6.2.4. Spain 6.2.5. France 6.2.6. Rest of Europe 6.3. Asia-Pacific 6.3.1. China 6.3.2. India 6.3.3. Japan 6.3.4. Rest of Asia-Pacific 6.4. Rest of the World

7. Company Profiles 7.1. Abbott Laboratories 7.2. Allergan plc 7.3. Axonics Modulation Technologies, Inc. 7.4. B. Braun Melsungen AG 7.5. Boston Scientific Corp. 7.6. Dispomedica GmbH 7.7. Integra LifeSciences Holdings Corp. 7.8. Johnson & Johnson Services Inc. 7.9. LivaNova PLC 7.10. Magstim Co. Ltd. 7.11. Medtronic plc 7.12. Mller Medical GmbH 7.13. Natus Medical Inc. 7.14. NeuroPace, Inc. 7.15. Nevro Corp. 7.16. Nihon Kohden Corp. 7.17. Penumbra, Inc. 7.18. Saluda Medical Pty Ltd. 7.19. Smith & Nephew plc 7.20. Stryker Corp. 7.21. W. L. Gore & Associates, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/hfglec

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Formats available:

Here is the original post:
Insights on the Neurology Devices Global Market to 2025 - Detailed and Extensive Market Overview with Key Analyst Insights - GlobeNewswire